Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study

BACKGROUND. The EACH study assessed the efficacy of oxaliplatin, 5-fluorouracil, and leucovorin (the FOLFOX4 regimen) compared with doxorubicin alone in terms of overall survival (OS), progression-free survival (PFS), and safety in patients with advanced hepatocellular carcinoma (HCC). We present th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Qin, Shukui, Cheng, Ying, Liang, Jun, Shen, Lin, Bai, Yuxian, Li, Jianfeng, Fan, Jia, Liang, Lijian, Zhang, Yaqi, Wu, Gang, Rau, Kun-Ming, Yang, Tsai-Shen, Jian, Zhixiang, Liang, Houjie, Sun, Yan
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2014
Témata:
Hepatobiliary
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221370/
https://ncbi.nlm.nih.gov/pubmed/25223462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0190
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky